Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Waiora is a private consumer health company that markets and sells wellness and nutritional supplement products, with a particular focus on liquid zeolite formulations promoted for detoxification, immune support, and healthy aging. The company appears to operate primarily through e-commerce and direct-selling style distribution rather than through a traditional pharmaceutical or biotechnology R&D model. Publicly visible products include Natural Cellular Defense (NCD), NCD2, and MegaDefense. Based on the available evidence, Waiora is active in the broader health and wellness sector, but it does not appear to be a drug-development biotech, pharma, or clinical-stage therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Waiora.